#Oncology M&amp;A activity over the last five years.

The takeouts represented a median premium of 75% and 7.3x median multiple of sales.

Acquirers: $PFE $GILD $CELG $BMY $LLY $ABBV $TAK $GSK $AZN $MRK $SNY $NVS $RHHBY $SGEN

Relevant to: $RCUS $IOVA $KPTI $EPZM $EXEL $DCPH $FATE https://t.co/RufP9GEffu